<DOC>
	<DOCNO>NCT00475410</DOCNO>
	<brief_summary>Anal fistula define abnormal communication anal canal perianal skin . Adipose-derived stem cell new therapy closure fistula . This study test safety efficacy ASCs ( adipose stem cell ) treatment patient without Crohn´s disease .</brief_summary>
	<brief_title>Efficacy Safety Adipose Stem Cells Treat Complex Perianal Fistulas Not Associated Crohn´s Disease</brief_title>
	<detailed_description>Perianal fistula account 10 % 30 % coloproctological surgical procedure . Currently accept conventional treatment surgery intend treat tract use different technical option . This surgery usually highly bothersome postoperative period may involve two major complication : anal incontinence recurrence . The biological property stem cell derive adult tissue make adequate candidate treatment diseases tissue damage heal process alter . This study compare efficacy ASCs versus ASCs plus Fibrin adhesive versus Fibrin adhesive alone closure complex perianal fistula associate Inflammatory Bowel Disease . Fistula closure define absence suppuration re-epithelization external opening clinical evaluation absence collection &gt; 2 cm directly relate fistula tract treat , measure MRI</detailed_description>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Rectal Fistula</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>1 . Patient complex perianal fistula . A complex perianal fistula must meet one follow : No fistula tract palpate perianal skin tract parallel rectum examination stylet . Associated anal incontinence transsphincteric fistula . Risk factor anal incontinence . At least one prior surgery fistulous disease . Suprasphincteric tract show image test . 2 . Women childbearing age negative serum urine pregnancy test ( sensitive 25IU hCG ) lactating study entry . Both men woman use adequate birth control method define investigator . 3 . Seton presence allow time study entry cell ( group receive ASCs ) Fibrin adhesive implant . 4 . No condition may prevent patient follow study procedure 26 week followup complete foreseen . 5 . Patient give his/her sign , write informed consent . 1 . Patient diagnose IBD 2 . Patient rectovaginal fistula 3 . Patient pregnant lactate woman 4 . Patient acute sepsis time study entry 5 . A liposuction draw least 100 cc fat abdominal wall technically feasible . 6 . Patient need surgery perianal region reason fistulas 7 . Presence two complex perianal fistula 8 . Patient collection &gt; 2 cm MRI . If collection exist , surgeon may perform complete toilette area . 9 . Patient allergic local anesthetic Gadolinium ( MRI contrast agent ) . 10 . MRI technically feasible . 11 . Patient abuse alcohol addictive substance within 6 month study entry . 12 . Patient active latent infection HIV , HBV HCV . 13 . Patient undergone major surgery sustain severe trauma , investigator 's judgment , within 28 day recruitment . 14 . Patient receive receive immunomodulatory treatment reason fistula within 6 month study entry . 15 . Patient malignant tumour , except basal squamous cell carcinoma skin , prior history malignant tumour , except tumour remission least past 5 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Autologous adipose-derived stem cell</keyword>
	<keyword>Complex perianal fistula</keyword>
	<keyword>Inflammatory Bowel Disease</keyword>
	<keyword>Advanced cell therapy</keyword>
	<keyword>Fibrin glue</keyword>
</DOC>